@article{MTMT:37077507,
	title = {Multidimensional effects of genetic mechanisms in cancer occurrence, development and treatment},
	url = {https://m2.mtmt.hu/api/publication/37077507},
	author = {Wang, X. and Shi, X. and Liao, S. and Su, T. and Gu, Y. and Zhang, H. and Li, Z.},
	doi = {10.1016/j.cancergen.2026.03.006},
	journal-iso = {CANCER GENET},
	journal = {CANCER GENETICS},
	volume = {304-305},
	unique-id = {37077507},
	issn = {2210-7762},
	year = {2026},
	eissn = {2210-7770},
	pages = {58-75}
}

@article{MTMT:36249108,
	title = {Case Report: Pituitary metastasis from prostate adenocarcinoma: an integrated diagnosis via 68Ga-PSMA PET/CT and methylome analysis},
	url = {https://m2.mtmt.hu/api/publication/36249108},
	author = {Bianchetto, Wolf N. and Mainta, I.C. and Fitsiori, A. and Colarusso, G. and Tsantoulis, P. and Egervari, K.L. and Garibotto, V.},
	doi = {10.3389/fmed.2025.1618256},
	journal-iso = {FRONT MED},
	journal = {FRONTIERS IN MEDICINE},
	volume = {12},
	unique-id = {36249108},
	year = {2025},
	eissn = {2296-858X}
}

@article{MTMT:35881728,
	title = {Ancestry-Specific DNA Damage Repair Gene Mutations and Prostate Cancer},
	url = {https://m2.mtmt.hu/api/publication/35881728},
	author = {Borbiev, Talaibek and Babcock, Kevin and Sinopole, Kayleigh and Chesnut, Gregory T. and Petrovics, Gyorgy},
	doi = {10.3390/cancers17040682},
	journal-iso = {CANCERS},
	journal = {CANCERS},
	volume = {17},
	unique-id = {35881728},
	keywords = {Prostate cancer; Germline mutations; SOMATIC MUTATIONS; DNA damage repair genes},
	year = {2025},
	eissn = {2072-6694}
}

@article{MTMT:35724858,
	title = {Prostate cancer epigenetics - from pathophysiology to clinical application},
	url = {https://m2.mtmt.hu/api/publication/35724858},
	author = {Constancio, Vera and Lobo, Joao and Sequeira, Jose Pedro and Henrique, Rui and Jeronimo, Carmen},
	doi = {10.1038/s41585-024-00991-8},
	journal-iso = {NAT REV UROL},
	journal = {NATURE REVIEWS UROLOGY},
	volume = {22},
	unique-id = {35724858},
	issn = {1759-4812},
	abstract = {Prostate cancer is a multifactorial disease influenced by various molecular features. Over the past decades, epigenetics, which is the study of changes in gene expression without altering the DNA sequence, has been recognized as a major driver of this disease. In the past 50 years, advancements in technological tools to characterize the epigenome have highlighted crucial roles of epigenetic mechanisms throughout the entire spectrum of prostate cancer, from initiation to progression, including localized disease, metastatic dissemination, castration resistance and neuroendocrine transdifferentiation. Substantial advances in the understanding of epigenetic mechanisms in the pathophysiology of prostate cancer have been carried out, but translating preclinical achievements into clinical practice remains challenging. Ongoing research and biomarker-oriented clinical trials are expected to increase the likelihood of successfully integrating epigenetics into prostate cancer clinical management.},
	keywords = {androgen receptor; DNA methyltransferase; TUMOR-SUPPRESSOR; PHASE-II; EZH2; PROMOTER METHYLATION; LINEAGE PLASTICITY; Recurrence-free survival; Biochemical recurrence},
	year = {2025},
	eissn = {1759-4820},
	pages = {447-469},
	orcid-numbers = {Constancio, Vera/0000-0002-3151-0367; Lobo, Joao/0000-0001-6829-1391; Sequeira, Jose Pedro/0000-0002-4687-3347; Henrique, Rui/0000-0003-3171-4666; Jeronimo, Carmen/0000-0003-4186-5345}
}

@article{MTMT:36249109,
	title = {Alterations in AR-FOXA1 signaling in prostate cancer progression and therapeutic resistance},
	url = {https://m2.mtmt.hu/api/publication/36249109},
	author = {Gao, S. and Patten, N.D. and Cai, C.},
	doi = {10.1016/j.jncc.2025.05.003},
	journal-iso = {J. Natl. Cancer Cent.},
	journal = {JOURNAL OF THE NATIONAL CANCER CENTER},
	volume = {6},
	unique-id = {36249109},
	issn = {2096-8663},
	year = {2025},
	eissn = {2667-0054},
	pages = {58-72}
}